Top compounds associated with response to NAT9


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib FIMM pan-cancer AAC 0.31 0.04
mRNA ML311 CTRPv2 pan-cancer AAC -0.065 0.04
mRNA semagacestat CTRPv2 pan-cancer AAC -0.074 0.04
mRNA blebbistatin CTRPv2 pan-cancer AAC -0.15 0.05
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.062 0.05
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.074 0.05
mRNA cimetidine CTRPv2 pan-cancer AAC 0.13 0.05
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.063 0.05
mRNA Irinotecan FIMM pan-cancer AAC 0.21 0.05
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.061 0.05
Download CSV